These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6276631)

  • 1. [Captopril inhibits angiotensin converting enzyme. New principles for therapy in hypertension and heart failure].
    Ohman KP; Karlberg BE
    Lakartidningen; 1981 Nov; 78(45):4039-41. PubMed ID: 6276631
    [No Abstract]   [Full Text] [Related]  

  • 2. Captopril and enalapril: angiotensin converting enzyme (ACE) inhibitors.
    Ferguson RK; Vlasses PH; Riley LJ
    Ration Drug Ther; 1984 Mar; 18(3):1-5. PubMed ID: 6093192
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect and tolerance of the angiotensin-converting enzyme inhibitor captopril (Tensobon)].
    Rahn KH; Stumpe KO
    MMW Munch Med Wochenschr; 1984 Feb; 126 Suppl 1():S5-14. PubMed ID: 6323979
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of angiotensin-converting enzyme: therapeutic implications.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Isr J Med Sci; 1982 Oct; 18(10):981-5. PubMed ID: 6293997
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibitors.
    Dipalma JR
    Am Fam Physician; 1980 Nov; 22(5):164-5. PubMed ID: 6158857
    [No Abstract]   [Full Text] [Related]  

  • 6. Measurements of angiotensin converting enzyme in captopril-treated patients.
    Kamoun PP; Bardet JI; Di Giulio S; Grunfeld JP
    Clin Chim Acta; 1982 Feb; 118(2-3):333-6. PubMed ID: 6276050
    [No Abstract]   [Full Text] [Related]  

  • 7. [Captopril in refractory advanced cardiac insufficiency].
    Bechtold H; Philipp T
    Med Klin Prax; 1982 Apr; 77(8):34-41. PubMed ID: 6281632
    [No Abstract]   [Full Text] [Related]  

  • 8. [Captopril (Tensobon) in practical use in hypertension and heart failure].
    Philipp T; Lederle RM
    MMW Munch Med Wochenschr; 1984 Feb; 126 Suppl 1():S15-23. PubMed ID: 6424002
    [No Abstract]   [Full Text] [Related]  

  • 9. [Captopril - profile of a new antihypertensive (author's transl)].
    Gross F
    MMW Munch Med Wochenschr; 1981 Nov; 123(47):1803-9. PubMed ID: 6796855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Captopril.
    Hanna M; Fitz A
    J Iowa Med Soc; 1983 Oct; 73(10):415-7. PubMed ID: 6358377
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of heart failure. Value of a causal approach].
    Liebau G
    Fortschr Med Suppl; 1985; 1():12-5. PubMed ID: 2858437
    [No Abstract]   [Full Text] [Related]  

  • 12. Captopril: worldwide clinical experience.
    Tarazi RC
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):69S-251S. PubMed ID: 6753906
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of chronic congestive cardiac insufficiency with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
    Guerrera G; Melina D
    Minerva Cardioangiol; 1983 Mar; 31(3):93-100. PubMed ID: 6304571
    [No Abstract]   [Full Text] [Related]  

  • 14. More on captopril and measurement of angiotensin-converting enzyme.
    Dux S; Rosenfeld J; Yaron A; Carmel A
    N Engl J Med; 1981 Feb; 304(7):423-4. PubMed ID: 6256629
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of captopril in the management of cardiac failure.
    Cleland JG; Dargie HJ; Robertson JI; Ball SG; Hodsman GP
    Scott Med J; 1984 Apr; 29(2):129-30. PubMed ID: 6099613
    [No Abstract]   [Full Text] [Related]  

  • 16. The measurement of angiotensin-converting enzyme in subjects receiving captopril.
    Roulston JE; MacGregor GA
    N Engl J Med; 1980 Aug; 303(7):397. PubMed ID: 6248782
    [No Abstract]   [Full Text] [Related]  

  • 17. Assay of plasma angiotensin-converting enzyme activity in captopril-treated subjects.
    Lijnen P; Staessen J; Amery A
    Methods Find Exp Clin Pharmacol; 1982; 4(6):413-5. PubMed ID: 6292595
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress in vasodilator therapy for heart failure.
    Cohn JN
    N Engl J Med; 1980 Jun; 302(25):1414-6. PubMed ID: 6246428
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiotensin converting enzyme inhibition: a new therapeutic modality.
    Gavras H; Charocopos F; Brunner H; Gavras I
    Bull N Y Acad Med; 1981 May; 57(4):304-10. PubMed ID: 6164426
    [No Abstract]   [Full Text] [Related]  

  • 20. Beneficial haemodynamic effect of the angiotensin blocking agent captopril in patients with refractory heart failure.
    Lee CL; MacDonald GJ; Walsh WF
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():93-7. PubMed ID: 6291831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.